SBS.F - Stratec SE

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Stratec SE

Gewerbestrasse 35-37
Birkenfeld 75217
Germany
49 7082 7916 0
http://www.stratec.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees1,282

Key Executives

NameTitlePayExercisedYear Born
Mr. Marcus WolfingerChairman of Board of Management & CEO577kN/A1967
Dr. Robert SiegleDirector of Fin. & HR and Member of Board of Management469kN/A1967
Dr. Claus VielsackDirector of Product Devel. & Member of Board of Management405kN/A1967
Mr. Hermann LeistnerFounder & AdvisorN/AN/A1946
Sandra EberleHead of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

STRATEC SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates in three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to STRATEC SE in December 2018. STRATEC SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Corporate Governance

Stratec SE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.